CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-12 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +1,424 | $0.03 | $47 | 757,913 |
| 2020-10-12 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +6,076 | $0.03 | $201 | 763,989 |
| 2020-10-12 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $14.89 | $112K | 756,489 |
| 2020-10-12 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −1,424 | 0 | ||
| 2020-10-12 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −6,076 | 0 | ||
| 2020-10-12 | Shacham Sharon President & CSO | Exercise or conversion | +1,424 | $0.03 | $47 | 757,913 |
| 2020-10-12 | Shacham Sharon President & CSO | Exercise or conversion | +6,076 | $0.03 | $201 | 763,989 |
| 2020-10-12 | Shacham Sharon President & CSO | Sale | −7,500 | $14.89 | $112K | 756,489 |
| 2020-10-12 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −1,424 | 0 | ||
| 2020-10-12 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −6,076 | 0 | ||
| 2020-09-08 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +10,054 | $6.54 | $66K | 14,703 |
| 2020-09-08 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −10,054 | $14.98 | $151K | 4,649 |
| 2020-09-08 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −10,054 | 0 | ||
| 2020-08-28 | Oliger Christy J. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +32,800 | 32,800 | ||
| 2020-08-26 | DEMAREE JOHN Chief Commercial Officer | Purchase | +7,500 | $14.54 | $109K | 7,500 |
| 2020-08-17 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +1,477 | $0.03 | $49 | 757,966 |
| 2020-08-17 | Kauffman Michael Chief Executive Officer | Sale | −1,477 | $15.00 | $22K | 756,489 |
| 2020-08-17 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −1,477 | 6,076 | ||
| 2020-08-17 | Shacham Sharon President & CSO | Exercise or conversion | +1,477 | $0.03 | $49 | 757,966 |
| 2020-08-17 | Shacham Sharon President & CSO | Sale | −1,477 | $15.00 | $22K | 756,489 |
Page 21 of 29 · 570 trades